Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
The company has been in a very positive evolution with new CEO and mix of new and existing leadership team. Clear commitment to strong and positive culture, people, patients and results.
Was ist das Beste an Ihrem Vergütungspaket?
Fair evaluation of goals and receipt of bonus
Was macht Sie bei der Arbeit am glücklichsten?
trial results that focus on patients
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
actively being evolved with clear commitment to people, teams and patients
Was gefällt dir am besten am Führungsteam?
Actively evolved from past control and command to engaged, aligned and capable team!!
Was sind einige der besten Dinge an Ihrem Team?
Increasingly aligned and capable with a strong commitment to work together and lack of politics
Other Employee Reviews for Karyopharm Therapeutics
×